Fundamentals in Urology Bundle (2018)

Philadelphia, PA US
June 8, 2018 to June 10, 2018

The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. NEW this year, the course has been redesigned to 3 days to allow for less time out of the office and in a convenient location for traveling out of state! This course will provide attendees with valuable skills in developing a rational methodological approach to application of knowledge which will contribute to positive outcomes for patients. New topics for this year include Reflux, Obstruction, and Undescended Testes- Causes and Clinical Implications and Medical and Surgical Management of ED. Attendees will discover the importance of the study of basic sciences and how it transfers into the lifelong learning process and medical practice. This course is designed to ensure a fundamental knowledge of the "why" behind a broad expanse of general urologic conditions. A thorough knowledge of the basic science behind the treatments will allow for better counseling and education of patients by all clinical urologic practitioners.

Target Audience

  • Urology Residents
  • Allied Health Professionals

Learning Objectives

After attending this course, participants will be able to:

Nephrolithiasis and Infections

  • Recognize the basic pathophysiology of nephrolithiasis.
  • Identify the indications and options for the medical evaluation of recurrent and first time stone formers.
  • Establish an effective algorithm for the medical management of nephrolithiasis.
  • Distinguish the appropriate timing of diagnostic methods for treatment of bacteria and fungi in the urinary tract.

Incontinence, Ethics, Obstruction, and Pelvic Pain

  • Recall the pathophysiology of pelvic organ prolapse and stress incontinence.
  • Describe how to treat pelvic organ prolapse and stress incontinence conditions.
  • Review foundational concepts of bioethics.
  • Define the meaning of “profession”.
  • Discuss key aspects of consent, capacity, research and ethics.
  • Identify how to apply consent, capacity, research and ethics to the practice of urology.
  • Recognize the role of prophylacitic antibiotics and lower urinary tract imaging for prenatal urinary tract dilation.
  • Define the true incidence of IC/BPS and CP/CPPS in the US population.
  • Recall what is currently believed about the pathophysiology of chronic pelvic pain.
  • Recognize how to use the AUA guidelines to develop a treatment plan for patients with IC/BPS and CP/CPPS.
  • Describe current research in pelvic pain and possible new treatment options.

Minimally Invasive Surgery, BPH, Outcomes and Pediatrics

  • Identify the physics underlying laser energy, complications occurring due to pneumoperitoneum, and optimizing delivery of shock wave energy.
  • Define the medical therapies designed to address benign enlargement of the prostate.
  • Explain the basic development of the lower and upper urinary tract including the bladder, kidney and ureters.
  • Identify clinical situations that may be encountered if aberrant development occurs in any of the above organ systems.
  • Recognize the validity of randomized clinical trials.
  • Recognize how to apply the results of outcomes research to clinical practice.

Imaging and Prostate Cancer

  • Describe the history of M1 Prostate cancer therapies.
  • Identify basics in ADT management.
  • Discuss basic science and clinical outcomes of new therapies.
  • Identify the appropriate indications for MRI and the basic MRI sequences used in urinary tract imaging.
  • Distinguish benign from malignant renal masses.
  • Recognize how an MRI of the prostate and urethra can be useful and the key features of prostate tumor on MRI.

Adrenal and Renal Physiology, Bowel Diversions, and Bladder Cancer

  • Describe how fundamentals of adrenal anatomy and physiology integrate into the care of the urologic patient.
  • Discuss renal physiology for the urologist, especially for the following pathologic states: TUR syndrome, upper urinary tract obstruction, post-obstructive diuresis, pregnancy, renovascular hypertension, and juxtaglomerular tumor.
  • Review the major genetic alterations that are present in bladder cancers.
  • Define “intrinsic subtypes”.
  • Discuss their implications for disease heterogeneity and precision medicine
  • Review current understanding of immunotherapy for treatment of bladder cancer.
  • Explain rationale for choosing a urinary diversion based on the metabolic derangements associated with each segment of bowel.

Male Infertility, Disorders of Differentiation, and Kidney Cancer

  • Explain male reproductive anatomy and physiology.
  • Discuss a basic clinical overview of male reproductive medicine and surgery.
  • Describe the current clinical and surgical management of all types of localized as well as advanced kidney cancer.

PSA and the Prostate, Neurogenic Bladder, and Reproductive Biology

  • Review the current data on the controversies, clinical trials and laboratory testing for prostate cancer screening in asymptomatic men.
  • Explain lower urinate tract neurobiology and how disease processes, such as neurologic disease; result in predictable lower urinary tract dysfunction.
  • Describe penile anatomy and the physiology of erection.
  • Describe the major causes of erectile dysfunction.
  • Identify the basic classification, diagnosis and treatment of female sexual dysfunction.
Course summary
Available credit: 
  • 33.50 AMA PRA Category 1 Credit™
  • 33.50 Non-Physician Participation
Course opens: 
03/16/2018
Course expires: 
06/10/2021
Event starts: 
06/08/2018 - 7:30am
Event ends: 
06/10/2018 - 12:45pm
Price:
$955.00
Rating: 
0

Friday, June 8, 2018

7:00 – 7:30 am             Continental Breakfast and Registration

7:30 – 7:45 am             Housekeeping Notes

Session 1:                     Stones, Urodynamics and Inflammation

7:45 – 9:15 am             Nephrolithiasis: Physiology, Metabolic Workup and Treatment of Stones

                                    Glenn Preminger, MD

9:15 – 9:30 am             Break

9:30 – 10:30 am          Urodynamics

                                       Mikel Gray, PhD

10:30 – 11:30 am        Interstitial Cystitis and Disorders of Pelvic Pain

                                       Robert J. Evans, MD, FACS

11:30 am – 12:30 pm  Lunch & Learn with the Experts (Others on Own)

Session 2:                    Pediatrics

12:30 1:30 pm           Embryology, Congenital Anomalies, and Disorders of Sexual Differentiation

                                        Patricio C. Gargollo, MD

1:30 – 2:30 pm            Reflux, Obstruction, and Undescended Testes – Causes and Clinical Implications   

                                       Shukla Aseem, MD

2:30 – 2:45pm             Break

Session 3:                    Urologic Imaging and Infections

2:45 – 4:00 pm            MRI for Urologists

                                   Nabeel Sarwani, MD

4:00 – 5:15 pm            Urologic Infections: Etiology, Patterns and Pathophysiology

                                       Michel A. Pontari, MD

5:15 – 5:30 pm            Course Evaluation      

Saturday, June 9, 2018

7:00 – 7:45 am             Continental Breakfast

7:30 7:45 am              Housekeeping Notes

Session 4:                    BPH and Science of Minimally Invasive Surgery

7:45 – 8:45 am             BPH: Pathophysiology, Drugs, and Trials

                                        Richard K. Lee, MD

8:45 – 9:45 am            Lasers, Laparoscopes, and Lithotripters: The Science of Minimally Invasive Urology

                                       Jay D. Raman, MD, FACS

9:45 – 10:00 am          Break

Session 5:                    Infertility and Erectile Dysfunction

10:00 – 11:00 am        Infertility and Reproductive Biology in Women and Men

                                       Cigdem Tanrikut, MD

11:00 am – 12:00 pm  Medical and Surgical Management of ED

                                       John Mulhall, MD

12:00 – 12:45 pm        Lunch & Learn with the Experts (Others on Own)

12:45- 1:00 pm            AUA Update

                                      Victor Nitti, MD

Session 6:                 Prostate Cancer

1:00 2:00 pm           PSA, Urine Markers and the Science of Cancer Screening

                                    Leonard G. Gomella, MD, FACS

2:00 – 3:00 pm          Management of Advanced Prostate Cancer: Drugs, Mechanisms, Disease, Epidemiology and                                            Molecular Mechanisms

                                      Michael B. Williams, MD

3:00 – 3:15 pm            Break

Session 7:                    Bladder Neurobiology and Pelvic Organ Prolapse

3:15 – 4:15 pm            Lower Urinary Tract Neurobiology and Functional Bladder Disorders

                                       Gary Lemack, MD

           

4:15 – 5:15 pm            Pelvic Organ Prolapse and SUI: Mechanisms and Mechanics

                                       Victor Nitti, MD

5:15 – 5:30 pm            Course Evaluation

6:00 7:00 pm              Saturday Night Social

Sunday, June 10, 2018

7:00 – 7:30 am            Continental Breakfast and Registration

7:30 – 7:45 am            Housekeeping Notes

Session 8:                    Bladder Cancer and Bowel Diversions

7:45 – 8:45 am            Basic Science of Bladder Cancer

                                       Trinity J. Bivalacqua, MD

8:45 – 9:45 am            Bowel Diversions: Physiology Underlying Electrolyte Abnormalities

                                       Tracey Krupski, MD, MPH

9:45‐ 10:00 am           Break

Session 9:                    Adrenal Disorders and Kidney Cancer

10:00 – 11:00 am        Adrenal Physiology

                                       Alexander Kutikov, MD, FACS

11:00am – 12:30 pm   Molecular Genetics and Principles of Molecular Therapeutics of Kidney Cancer

                                        W. Marston Linehan, MD

12:30 – 12:45pm         Course Evaluation and Meeting Adjourn

Doubletree Hilton City Center
237 South Broad Street
Philadelphia, PA 19107
United States

Travel

Doubletree by Hilton Hotel
237 South Broad Street
Philadelphia, PA 19107
215-983-1600
Website

Make your reservation today!

To hold a reservation, a major credit card number must be provided.

Reference the American Urological Association when making your reservation to receive the special group rate.

To hold a reservation, a major credit card number must be provided. $169 single/double occupancy. Reference the American Urological Association Fundamentals in Urology Course when making your reservation to receive the special group rate.

Cut-off Date

Monday, May 8, 2018. Once the AUA group block is full, which may be prior to the cut-off date, the AUA is unable to guarantee rooms at this rate or at this hotel.

Check-in: 3 p.m.
Check-out: 11 a.m.

Parking

Self-parking: $30.00 per day (overnight)
Valet: $44.00 per day (overnight)

Transportation

Car Rental

Hertz is pleased to offer special discounted car rental rates to AUA course and meeting attendees. Make your car rental reservation online or call 1-800-654-2240 and mention the AUA discount code, CV# 04SG0005.

Know Before You Go

Tourism

The DoubleTree by Hilton Hotel Philadelphia Center City enjoys an ideal location in the heart of Philadelphia's theater district on the Avenue of the Arts. Philadelphia's business district, nightlife and main attractions are minutes from the hotel.

Take in all the sights and sounds of Broad Street such as the Academy of Music across from the hotel, the Kimmel Center for the Performing Arts and Merriam Theater. Choose from a range of restaurants on Walnut Street's 'Restaurant Row' a block away. Visit the Philadelphia Museum of Art with more than 300,000 works of art. Enjoy sporting events at the Philadelphia Sports Complex, home of the Eagles, Phillies, Flyers and Sixers, located two miles away. The city has much to offer every guest!

 Faculty Disclosures:   
NameCompanyRoleFinancial
Trinity J. Bivalacqua, MDphotocureMeeting Participant or Lecturer,Scientific Study or TrialNo
tarisScientific Study or TrialNo
tarisScientific Study or TrialNo
FKDScientific Study or TrialNo
GenetechScientific Study or TrialNo
Robert J. Evans, MDallerganScientific Study or TrialYes
urigenInvestment InterestYes
allerganScientific Study or TrialYes
TARISScientific Study or TrialYes
aquinoxConsultant or Advisor,Scientific Study or TrialYes
Patricio C. Gargollo, MDIntuitive SurgicalMeeting Participant or LecturerYes
Leonard G. Gomella, MDAstellasConsultant or AdvisorYes
JanssenConsultant or AdvisorYes
Wolters KluwerHealth PublishingYes
McGraw HillHealth PublishingYes
Merck ManualHealth PublishingYes
Canadian Journal of UrologyHealth PublishingYes
MDx HealthConsultant or AdvisorYes
Merck PharmaceuticalsConsultant or AdvisorYes
BayerConsultant or AdvisorYes
Mikel L. Gray, Ph.D.Laborie MedicalScientific Study or TrialYes
3M IncConsultant or AdvisorYes
Tracey Krupski, MDArgosScientific Study or TrialNo
FKD - InstilidrinScientific Study or TrialNo
American Cancer SocietyScientific Study or TrialYes
NIHScientific Study or TrialNo
Alexander Kutikov, MDUrologyMatch.com LLCLeadership PositionYes
Visible Health, IncLeadership PositionYes
Richard K. Lee, MD 
Gary E. Lemack, MDAllerganConsultant or Advisor,Meeting Participant or LecturerYes
RoivantConsultant or AdvisorYes
AvadelConsultant or AdvisorYes
W. Marston Linehan, MD 
John P. Mulhall, MDAssociation of Peyronie's Disease Advocates (APDA)Leadership PositionNo
Victor W. Nitti, MDAstellasHealth Publishing,Scientific Study or TrialNo
AllerganHealth Publishing,Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
MedtronicScientific Study or TrialNo
Michel A. Pontari, MDLillyConsultant or AdvisorYes
aquinoxConsultant or Advisor,Scientific Study or TrialYes
Glenn M. Preminger, MDBoston ScientificConsultant or AdvisorYes
UpToDateHealth PublishingYes
RetrophinConsultant or Advisor,Meeting Participant or LecturerYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
MDx HealthScientific Study or TrialNo
Nabeel Sarwani, MD 
Aseem R. Shukla, MD 
Cigdem Tanrikut, MDNew England Cryogenic CenterOtherYes
Fertility Research and PracticeHealth PublishingNo
Michael B. Williams, M.D.AstellasScientific Study or TrialNo
JannsenScientific Study or TrialNo
Pacific Edge DiagnosticsConsultant or AdvisorYes
    
Online Educational Modules and Optional Course Faculty:   
NameCompanyRoleFinancial
Mikel L. Gray, Ph.D.Laborie MedicalMeeting Participant or LecturerYes
3M Inc.Consultant or AdvisorYes
C.D. Anthony Herndon, MD, FAAP, FACSNothing to disclose.
Gladell Paner, MDAmirsys, Inc.Health PublishingYes
Charles D. Scales Jr., MDNIH/National Institute on AgingScientific Study or TrialYes
Society of Urology Chairpersons and Program DirectorsScientific Study or TrialYes
Filament BiosolutionsScientific Study or TrialNo
NIH/ National Institute of Diabetics and Digestive and Kidney DiseasesScientific Study or TrialNo
GileadConsultant or AdvisorYes
Astra-ZenecaScientific Study or TrialYes
Eric A. Singer, MDNothing to disclose.
Necole M Streeper, M.D.Nothing to disclose.
    
Education Council Disclosures:
NameCompanyRoleFinancial
Michael R. Abern, MDDepartment of Defense Prostate Cancer Research ProgramScientific Study or TrialYes
 American Urological Association Office of EducationConsultant or AdvisorYes
 Department of Defense Prostate Cancer Research ProgramConsultant or AdvisorYes
Sero Andonian, MDLumenisMeeting Participant or Lecturer, Scientific Study or TrialYes
Timothy Charles Brand, MDNothing to disclose 
Anthony A. Caldamone, MDNothing to disclose 
Matthew S. Christman, MDNothing to disclose 
John D. Denstedt, MDCook UrologyOwner, Product DevelopmentYes
 Endourological SocietyLeadership PositionYes
 Endourological SocietyHealth PublishingYes
Jody DonaldsonNothing to disclose 
Shelby EnglertNothing to disclose 
Allen Gao, MD, PhDPandomedxLeadership Position, Owner, Product DevelopmentYes
Matthew Thomas Gettman, MDCOVR MedicalConsultant or AdvisorYes
 Intuitive SurgicalConsultant or AdvisorYes
 Exact SciencesScientific Study or TrialYes
Howard B. Goldman, MDallerganConsultant or AdvisorYes
 MedtronicConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 CookScientific Study or TrialNo
 NuvectraConsultant or AdvisorYes
 AxonicsConsultant or AdvisorYes
 NewUroConsultant or AdvisorYes
 GalvaniConsultant or AdvisorYes
 bionessScientific Study or TrialNo
William C. Huang, MDPhotocureScientific Study or TrialYes
 Karl StorzScientific Study or TrialYes
 IntuitiveMeeting Participant or LecturerYes
William C. Hulbert, Jr., MDNothing to disclose 
Brant Inman, MD, MS, FRCSCDendreonScientific Study or TrialNo
 Genentech IncScientific Study or TrialNo
 Combat MedicalConsultant or Advisor, Scientific Study or TrialYes
 FKD TherapiesScientific Study or TrialNo
 NucleixScientific Study or TrialYes
 UrogenScientific Study or TrialYes
Mark L. Jordan MD,FACSNothing to disclose 
Martin A. Koyle, MDNothing to disclose 
Yair Lotan, MDabbottScientific Study or TrialNo
 CepheidConsultant or Advisor, Scientific Study or TrialNo
 Pacific EdgeScientific Study or TrialNo
 FKDScientific Study or TrialNo
 MDxHealthConsultant or Advisor, Scientific Study or TrialYes
 biocancellScientific Study or TrialNo
 GenomeDx Biosciences IncScientific Study or TrialNo
 photocureConsultant or Advisor, Scientific Study or TrialNo
Nicole Lara Miller, MDBoston Scientific CorporationConsultant or Advisor, Meeting Participant or LecturerYes
 Practical Reviews In UrologyHealth PublishingYes
Manoj Monga, MD, FACSFortecOtherYes
Ajay Kumar Nangia, MBBS, FACSAUA NewsLeadership Position, Health PublishingYes
NIH CCN TrialScientific Study or TrialYes
Urology Care FoundationLeadership PositionNo
AUA Health Policy CouncilLeadership PositionNo
South Central AUALeadership PositionNo
ASRMLeadership PositionNo
Curtis Nickel, MDFarr LaboratoriesConsultant or AdvisorYes
AquinoxScientific Study or TrialNo
PureTech HealthConsultant or AdvisorYes
AUAHealth PublishingYes
NIHScientific Study or TrialYes
Canadian Institute of Health ResearchScientific Study or TrialYes
Interface BiologicsConsultant or AdvisorYes
Alvio TherapeuticsConsultant or AdvisorYes
Seikagaku CorporationConsultant or AdvisorYes
MedifocusConsultant or AdvisorYes
RedLeaf MedicalConsultant or AdvisorYes
Victor William Nitti, MDAstellasHealth Publishing, Scientific Study or TrialNo
AllerganHealth Publishing, Scientific Study or TrialNo
Serenity PharmeuticalsInvestment InterestYes
MedtronicScientific Study or TrialNo
Christopher Porter, MDNothing to disclose 
Ganesh V. Raj, MD, PhDPtaresOwner, Product DevelopmentYes
 C-diagnostics corpConsultant or Advisor, Investment InterestYes
 amgenMeeting Participant or LecturerYes
 Johnson and JohnsonConsultant or Advisor, Owner, Product DevelopmentYes
 AstellasMeeting Participant or LecturerYes
 ASTELLASConsultant or Advisor, Meeting Participant or LecturerYes
 JanssenOwner, Product DevelopmentYes
 BAYERConsultant or Advisor, Meeting Participant or LecturerYes
 SANOFIConsultant or Advisor, Meeting Participant or LecturerYes
 GaudiumRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
 MedivationConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 EtiraRxLeadership Position, Investment Interest, Owner, Product DevelopmentYes
Jay D. Raman, MDAmerican Kidney Stone ManagementInvestment InterestYes
MDx HealthScientific Study or TrialNo
Lee Richstone, MDNothing to disclose 
Heather SchultzSUNAMeeting Participant or LecturerYes
 SUNALeadership PositionNo
Karl-Dietrich Sievert, MD, PhDMedtronicsMeeting Participant or Lecturer, Scientific Study or TrialYes
 AllergenConsultant or Advisor, Meeting Participant or Lecturer, Scientific Study or TrialYes
 NeotractMeeting Participant or LecturerYes
 StimguardMeeting Participant or Lecturer, Scientific Study or TrialYes
Joseph A. Smith Jr., MDNothing to disclose 
Ryan Patrick Terlecki, MD, FACSAmerican Medical SystemsConsultant or Advisor, OtherYes
 Boston ScientificConsultant or AdvisorYes
 MicroGen DxConsultant or AdvisorYes
 U.S. Department of DefenseScientific Study or TrialYes
Edouard John Trabulsi, MD, FACSGenomeDxConsultant or AdvisorYes
 JanssenConsultant or Advisor, Meeting Participant or LecturerYes
 PfizerConsultant or Advisor, Meeting Participant or LecturerYes
 MerckMeeting Participant or LecturerYes

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity and enduring material for a maximum of 33.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

 

Available Credit

  • 33.50 AMA PRA Category 1 Credit™
  • 33.50 Non-Physician Participation

Accreditation Period

Course opens: 
03/16/2018
Course expires: 
06/10/2021

Price

Price:
$955.00
Please login or register to take this course.